{
  "docId": "019de074-2973-7208-9395-338d3116556a",
  "docSlug": "4059563425860536cb0bf09c6eb6bba5",
  "documentTitle": "BenevolentAI | Investor Conference Presentation Deck | 29 slides",
  "authorId": "benevolentai",
  "authorName": "BenevolentAI",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 16,
  "pageCount": 29,
  "prevPage": 15,
  "nextPage": 17,
  "slideType": "peer_benchmark",
  "function": "compare_peers",
  "density": "dense",
  "nDataPoints": 22,
  "notes": "The chart uses a segmented bar approach to compare established industry players against BenevolentAI's projected output.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-2973-7208-9395-338d3116556a/16",
  "deckHref": "/decks/019de074-2973-7208-9395-338d3116556a",
  "deckJsonHref": "/decks/019de074-2973-7208-9395-338d3116556a.json",
  "deckAnchorHref": "/decks/019de074-2973-7208-9395-338d3116556a#slide-16",
  "components": [
    {
      "bbox": {
        "h": 0.15,
        "w": 0.2,
        "x": 0.75,
        "y": 0.3
      },
      "kind": "callout",
      "text": "BenevolentAI potential productivity is in line with medium and large companies, but at a fraction of the total cost.",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "05b4ddf9-bb67-4001-bcde-87e4a510dd76",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.65,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "chart",
      "text": "Number of new INDs filed by year by pharma and biotech companies",
      "attrs": null,
      "subkind": "bar-horizontal",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bc582fae-dfb6-4e0a-8ada-f276d3e959c0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.2,
        "x": 0.75,
        "y": 0.5
      },
      "kind": "paragraph",
      "text": "BenevolentAI will aim to increase the number of INDs from its Platform with incremental cost largely from development through to the clinic only",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "589b1611-031b-428e-90a6-2e01841c5854",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.2,
        "x": 0.75,
        "y": 0.75
      },
      "kind": "source-note",
      "text": "Note *IND filing rate is based on Phase I trial starts with the company as the lead sponsor. Average adjusted for companies which started clinical development during time period; 1 Market cap as of 30/12/2022 (USD M). Source: clinicaltrials.gov ; Company websites: L.E.K. research & analysis",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "26fb378a-a428-405e-b095-30ee6ad8aae7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.7,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Our prolific drug discovery engine drives higher productivity",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "84eb1967-9c87-48b0-90d5-7a839a4d2cb5",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Slide recipe: the peer-gap chart",
      "slug": "peer-gap-chart-recipe",
      "agent": "designer",
      "layer": "slide",
      "matchId": "e70b6063-3555-4919-a7fe-95992e81b146",
      "evidence": "The bar chart comparing the number of new INDs filed by year by pharma and biotech companies, suggests a peer gap chart, which is a type of chart used for comparison.",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "peer_benchmark",
      "slug": null,
      "matchId": "5b539a62-5fd8-4179-be6d-9e37e900405d",
      "evidence": "Comparison of IND filing rates across industry peers categorized by commercial maturity.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 29,
      "from": 16,
      "beatId": "3b0e5288-2029-43c9-ada8-d64afac944d7",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Action",
      "beatSlug": "aida-action",
      "evidence": "The call to action is clear, with a roadmap and ask for investors",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}